[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

DNA Sequencer-Europe Market Status and Trend Report 2013-2023

May 2018 | 156 pages | ID: D0A5087D65AMEN
MIReports Co., Limited

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Summary

DNA Sequencer-Europe Market Status and Trend Report 2013-2023 offers a comprehensive analysis on DNA Sequencer industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Whole Europe and Regional Market Size of DNA Sequencer 2013-2017, and development forecast 2018-2023
Main market players of DNA Sequencer in Europe, with company and product introduction, position in the DNA Sequencer market
Market status and development trend of DNA Sequencer by types and applications
Cost and profit status of DNA Sequencer, and marketing status
Market growth drivers and challenges

The report segments the Europe DNA Sequencer market as:

Europe DNA Sequencer Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):

Germany
United Kingdom
France
Italy
Spain
Benelux
Russia

Europe DNA Sequencer Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):

Emulsion PCR
Bridge Amplification
Single-molecule
PCR

Europe DNA Sequencer Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)

Molecular Biology
Evolutionary Biology
Metagenomics
Medicine
Others

Europe DNA Sequencer Market: Players Segment Analysis (Company and Product introduction, DNA Sequencer Sales Volume, Revenue, Price and Gross Margin):

Roche
Illumina
Life Technologies
Beckman Coulter
Pacific Biosciences
Oxford Nanopore
Abbott Laboratories
GE Healthcare Life Sciences
Johnson & Johnson

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF DNA SEQUENCER

1.1 Definition of DNA Sequencer in This Report
1.2 Commercial Types of DNA Sequencer
  1.2.1 Emulsion PCR
  1.2.2 Bridge Amplification
  1.2.3 Single-molecule
  1.2.4 PCR
1.3 Downstream Application of DNA Sequencer
  1.3.1 Molecular Biology
  1.3.2 Evolutionary Biology
  1.3.3 Metagenomics
  1.3.4 Medicine
  1.3.5 Others
1.4 Development History of DNA Sequencer
1.5 Market Status and Trend of DNA Sequencer 2013-2023
  1.5.1 EMEA DNA Sequencer Market Status and Trend 2013-2023
  1.5.2 Regional DNA Sequencer Market Status and Trend 2013-2023

CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS

2.1 Market Status of DNA Sequencer in EMEA 2013-2017
2.2 Consumption Market of DNA Sequencer in EMEA by Regions
  2.2.1 Consumption Volume of DNA Sequencer in EMEA by Regions
  2.2.2 Revenue of DNA Sequencer in EMEA by Regions
2.3 Market Analysis of DNA Sequencer in EMEA by Regions
  2.3.1 Market Analysis of DNA Sequencer in Europe 2013-2017
  2.3.2 Market Analysis of DNA Sequencer in Middle East 2013-2017
  2.3.3 Market Analysis of DNA Sequencer in Africa 2013-2017
2.4 Market Development Forecast of DNA Sequencer in EMEA 2018-2023
  2.4.1 Market Development Forecast of DNA Sequencer in EMEA 2018-2023
  2.4.2 Market Development Forecast of DNA Sequencer by Regions 2018-2023

CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES

3.1 Whole EMEA Market Status by Types
  3.1.1 Consumption Volume of DNA Sequencer in EMEA by Types
  3.1.2 Revenue of DNA Sequencer in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
  3.2.1 Market Status by Types in Europe
  3.2.2 Market Status by Types in Middle East
  3.2.3 Market Status by Types in Africa
3.3 Market Forecast of DNA Sequencer in EMEA by Types

CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY

4.1 Demand Volume of DNA Sequencer in EMEA by Downstream Industry
4.2 Demand Volume of DNA Sequencer by Downstream Industry in Major Countries
  4.2.1 Demand Volume of DNA Sequencer by Downstream Industry in Europe
  4.2.2 Demand Volume of DNA Sequencer by Downstream Industry in Middle East
  4.2.3 Demand Volume of DNA Sequencer by Downstream Industry in Africa
4.3 Market Forecast of DNA Sequencer in EMEA by Downstream Industry

CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF DNA SEQUENCER

5.1 EMEA Economy Situation and Trend Overview
5.2 DNA Sequencer Downstream Industry Situation and Trend Overview

CHAPTER 6 DNA SEQUENCER MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA

6.1 Sales Volume of DNA Sequencer in EMEA by Major Players
6.2 Revenue of DNA Sequencer in EMEA by Major Players
6.3 Basic Information of DNA Sequencer by Major Players
  6.3.1 Headquarters Location and Established Time of DNA Sequencer Major Players
  6.3.2 Employees and Revenue Level of DNA Sequencer Major Players
6.4 Market Competition News and Trend
  6.4.1 Merger, Consolidation or Acquisition News
  6.4.2 Investment or Disinvestment News
  6.4.3 New Product Development and Launch

CHAPTER 7 DNA SEQUENCER MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA

7.1 Roche
  7.1.1 Company profile
  7.1.2 Representative DNA Sequencer Product
  7.1.3 DNA Sequencer Sales, Revenue, Price and Gross Margin of Roche
7.2 Illumina
  7.2.1 Company profile
  7.2.2 Representative DNA Sequencer Product
  7.2.3 DNA Sequencer Sales, Revenue, Price and Gross Margin of Illumina
7.3 Life Technologies
  7.3.1 Company profile
  7.3.2 Representative DNA Sequencer Product
  7.3.3 DNA Sequencer Sales, Revenue, Price and Gross Margin of Life Technologies
7.4 Beckman Coulter
  7.4.1 Company profile
  7.4.2 Representative DNA Sequencer Product
  7.4.3 DNA Sequencer Sales, Revenue, Price and Gross Margin of Beckman Coulter
7.5 Pacific Biosciences
  7.5.1 Company profile
  7.5.2 Representative DNA Sequencer Product
  7.5.3 DNA Sequencer Sales, Revenue, Price and Gross Margin of Pacific Biosciences
7.6 Oxford Nanopore
  7.6.1 Company profile
  7.6.2 Representative DNA Sequencer Product
  7.6.3 DNA Sequencer Sales, Revenue, Price and Gross Margin of Oxford Nanopore
7.7 Abbott Laboratories
  7.7.1 Company profile
  7.7.2 Representative DNA Sequencer Product
  7.7.3 DNA Sequencer Sales, Revenue, Price and Gross Margin of Abbott Laboratories
7.8 GE Healthcare Life Sciences
  7.8.1 Company profile
  7.8.2 Representative DNA Sequencer Product
  7.8.3 DNA Sequencer Sales, Revenue, Price and Gross Margin of GE Healthcare Life Sciences
7.9 Johnson & Johnson
  7.9.1 Company profile
  7.9.2 Representative DNA Sequencer Product
  7.9.3 DNA Sequencer Sales, Revenue, Price and Gross Margin of Johnson & Johnson

CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF DNA SEQUENCER

8.1 Industry Chain of DNA Sequencer
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis

CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF DNA SEQUENCER

9.1 Cost Structure Analysis of DNA Sequencer
9.2 Raw Materials Cost Analysis of DNA Sequencer
9.3 Labor Cost Analysis of DNA Sequencer
9.4 Manufacturing Expenses Analysis of DNA Sequencer

CHAPTER 10 MARKETING STATUS ANALYSIS OF DNA SEQUENCER

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

CHAPTER 11 REPORT CONCLUSION

CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE

12.1 Methodology/Research Approach
  12.1.1 Research Programs/Design
  12.1.2 Market Size Estimation
  12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
  12.2.1 Secondary Sources
  12.2.2 Primary Sources
12.3 Reference


More Publications